Arterial Stiffness as Surrogate End Point Needed Clinical Trials

被引：78
作者：
Laurent, Stephane [1 ]
Briet, Marie
Boutouyrie, Pierre
机构：
[1] Univ Paris 05, Dept Pharmacol, F-75015 Paris, France
来源：
HYPERTENSION | 2012年 / 60卷 / 02期
关键词：
CONVERTING ENZYME-INHIBITION; EXPERT CONSENSUS DOCUMENT; CORONARY-HEART-DISEASE; LEFT-VENTRICULAR MASS; AORTIC STIFFNESS; CARDIOVASCULAR EVENTS; MULTIPLE BIOMARKERS; EUROPEAN-SOCIETY; RISK; PREDICTION;
D O I：
10.1161/HYPERTENSIONAHA.112.194456
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：518 / 522
页数：5
相关论文
共 32 条
[31]   Prediction of coronary heart disease using risk factor categories [J].
Wilson, PWF ;
D'Agostino, RB ;
Levy, D ;
Belanger, AM ;
Silbershatz, H ;
Kannel, WB .
CIRCULATION, 1998, 97 (18) :1837-1847
[32]   Use of multiple biomarkers to improve the prediction of death from cardiovascular causes [J].
Zethelius, Bjorn ;
Berglund, Lars ;
Sundstrom, Johan ;
Ingelsson, Erik ;
Basu, Samar ;
Larsson, Anders ;
Venge, Per ;
Arnlov, Johan .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2107-2116
1234